Use of the Probiotic Limosilactobacillus reuteri as an Adjunct to Subgingival Instrumentation in the Treatment of Periodontitis Patients With Diabetes: A Randomised Clinical Trial.
- 2025-09-17
- RCT · n = 40
- Journal of clinical periodontology 53(1)
- Rocío Bujaldón
- Eduardo Montero
- Juan Daniel Gamonal
- Alejandro Abuelo
- María José Marín
- Margarita Iniesta
- Mariano Sanz
- David Herrera
- PubMed: 40958659
- DOI: 10.1111/jcpe.70035
- High evidence
- Clinical
Microbiological outcomes were similar.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- tablets containing L. reuteri for 3 months (exact dose not specified in abstract)